In this study, we evaluated the therapeutic efficacy of recombinant BMP9 in NAFLD mice and found that exogenous supplementation of BMP9 reduced obesity and hepatic steatosis and improved glucose metabolism. The gene discussed is GDF2; the disease is obesity due to melanocortin 4 receptor deficiency.